Volpara reaches milestone on breast imaging papers
October 18, 2021 -- New Zealand-based Volpara Health said the 200th peer-reviewed paper has been published about the use of its artificial intelligence (AI) technology. Read More
Dutch team uses AI to enhance value of MRI in dense breasts
October 7, 2021 -- Researchers from Utrecht in the Netherlands have developed an artificial intelligence (AI) model that dismissed nearly 40% of breast MRI scans without lesions while not missing any cancers in women with dense breasts. It offers hope as a triage tool, they say. Read More
Europe revises MRI guidelines to improve vulvar cancer staging
October 4, 2021 -- The European Society of Urogenital Radiology has issued new MRI guidelines in a bid to reduce ambiguity and improve radiology's role in the staging and management of patients with vulvar cancer. Read More
Dutch team assesses value of breast MRI in 4-year screening intervals
October 1, 2021 -- A research group from the Erasmus University Medical Center in Rotterdam has reported that MRI screening every four years is about 12% more cost-effective than mammography every two years for women with dense breasts. Read More